Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasminogen activator and cancer.

M J Duffy, P O'Grady

    European Journal of Cancer & Clinical Oncology
    |May 1, 1984
    PubMed
    Summary

    Elevated plasminogen activator levels in tumors may drive cancer growth and spread. Measuring this enzyme could aid in cancer diagnosis, prognosis, and identifying functional estrogen receptors in breast cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction: Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.

    British journal of cancer·2025
    Same author

    A zinc phthalocyanine-benzoperylenetriimide conjugate for solvent dependent ultrafast energy vs. electron transfer.

    Chemical communications (Cambridge, England)·2019
    Same author

    Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study.

    PloS one·2018
    Same author

    Pilomatrixoma or a "hair line fracture".

    Irish medical journal·2017
    Same author

    Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).

    European journal of cancer (Oxford, England : 1990)·2017
    Same author

    Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?

    International journal of cancer·2016

    Area of Science:

    • Biochemistry
    • Oncology
    • Molecular Biology

    Background:

    • Plasminogen activator (PA) is a protease converting plasminogen to active plasmin.
    • Elevated PA levels are observed in transformed cell lines and solid tumors compared to normal tissues.
    • Increased PA synthesis is implicated in cancer progression, invasion, and metastasis.

    Purpose of the Study:

    • To investigate the role of plasminogen activator in tumorigenesis.
    • To explore the diagnostic and prognostic potential of PA measurement in cancer.
    • To evaluate PA as a potential marker for estrogen receptor functionality in breast carcinomas.

    Main Methods:

    • Analysis of plasminogen activator levels in tumor extracts.
    • Measurement of plasminogen activator in various body fluids.
    • Assessment of estradiol inducibility of plasminogen activator.

    Main Results:

    • Transformed cells and tumors exhibit higher plasminogen activator production.
    • PA levels correlate with cancer invasion and metastasis.
    • Plasminogen activator is an estradiol-inducible enzyme.

    Conclusions:

    • Elevated plasminogen activator is associated with cancer development and spread.
    • PA measurement offers potential diagnostic and prognostic value in oncology.
    • PA may serve as a marker for estrogen receptor status in breast cancer.

    Related Experiment Videos